Interestingly, we find that the market is the darkest in the middle of the day. A lot of price discovery happens during the day – while traders are working on large orders searching for liquidity – ...
About This EventApogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest ...
The Philly Fed said its diffusion index for current general activity climbed to 16.3 in February from 12.6 in January, with a positive reading indicating growth. Economists had expected the index to ...
About This EventAurora (Nasdaq: ACB), the Canadian-based leading global medical cannabis company, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Miguel Martin, CEO & Executive ...
About This EventHennessy Capital Investment Corp. VIII (Nasdaq: HCICU), a SPAC focused on industrial technology, clean energy and critical minerals and mining, visits the Nasdaq MarketSite in Times ...
In that study, the trades were found to mostly be latency arbitrage opportunities, where orders hitting the dark pool were routed using faster microwave links. However, this could also happen because ...
About This EventNational Black Movie Association visits the Nasdaq MarketSite in Times Square.The National Black Movie ...
About This EventCrown Crafts, Inc. (Nasdaq: CRWS) visits the Nasdaq MarketSite in Times Square as they kick-off attendance at the North American International Toy Fair and celebrate the relaunch of ...
About This EventSOLV Energy (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, visits the Nasdaq MarketSite in Times Square.
About This EventPolaryx Therapeutics, Inc., (Nasdaq: PLYX), visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Alex Yang, Chairman and CEO rings the Closing Bell.
About This EventOlema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of ...
About This EventAgomAb Therapeutics NV (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with ...